Bristol Myers Squibb Acquires Cardiovascular Specialist MyoKardia for US$13.1 B
By Neha Madhwani & Michelle Liu
Pharma Deals Review: Vol 2020 Issue 10 (Table of Contents)
Published: 23 Oct-2020
DOI: 10.3833/pdr.v2020.i10.2565 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In the third largest M&A deal of 2020 so far, Bristol Myers Squibb (BMS) has agreed to acquire MyoKardia for US$13...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS